Vivos Therapeutics, Inc. Payments of Stock Issuance Costs
Vivos Therapeutics, Inc. (VVOS) reported Payments of Stock Issuance Costs of $487.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-20.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2026-08-14
- Vivos Therapeutics, Inc. payments of stock issuance costs for the quarter ending 2026-03-31 was $487.00K.
- Vivos Therapeutics, Inc. payments of stock issuance costs for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- Vivos Therapeutics, Inc. payments of stock issuance costs for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- Vivos Therapeutics, Inc. payments of stock issuance costs for the quarter ending 2024-12-31 was $446.00K, a 3.24% increase year-over-year.
- Vivos Therapeutics, Inc. payments of stock issuance costs for fiscal 2025 was $837.00K, a 38.50% decline from fiscal 2024.
- Vivos Therapeutics, Inc. payments of stock issuance costs for fiscal 2024 was $1.36M, a 26.37% increase from fiscal 2023.
- Vivos Therapeutics, Inc. payments of stock issuance costs for fiscal 2023 was $1.08M.
- Vivos Therapeutics, Inc. payments of stock issuance costs for fiscal 2021 was $2.24M, a 812.70% increase from fiscal 2020.
| Period end | Payments of Stock Issuance Costs 0 month | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|---|
| 2026-03-31 | $487.00K 10-Q · filed 2026-05-20 | $487.00K derived: sum of 2 quarters · filed 2026-05-20 | $487.00K derived: sum of 3 quarters · filed 2026-05-20 | ||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $0.00 derived: sum of 2 quarters · filed 2026-04-15 | $837.00K 10-K · filed 2026-04-15 | ||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | $837.00K 10-Q · filed 2025-11-19 | |||
| 2025-06-30 | $837.00K 10-Q · filed 2026-08-14 | ||||
| 2024-12-31 | $446.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $955.00K derived: sum of 2 quarters · filed 2026-04-15 | $1.05M derived: sum of 3 quarters · filed 2026-04-15 | $1.36M 10-K · filed 2026-04-15 | |
| 2024-09-30 | $509.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | $609.00K derived: sum of 2 quarters · filed 2025-11-19 | $915.00K 10-Q · filed 2025-11-19 | $1.35M derived: sum of 4 quarters · filed 2025-11-19 | |
| 2024-06-30 | $100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-19 | $406.00K 10-Q · filed 2025-08-19 | $838.00K derived: sum of 3 quarters · filed 2025-08-19 | $1.48M derived: sum of 4 quarters · filed 2025-08-19 | |
| 2024-03-31 | $306.00K 10-Q · filed 2025-05-15 | $738.00K derived: sum of 2 quarters · filed 2025-05-15 | $1.38M derived: sum of 3 quarters · filed 2025-05-15 | $1.38M derived: sum of 4 quarters · filed 2025-05-15 | |
| 2023-12-31 | $432.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $1.08M derived: sum of 2 quarters · filed 2025-03-31 | $1.08M derived: sum of 3 quarters · filed 2025-03-31 | $1.08M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $645.00K 10-Q · filed 2023-11-14 | $645.00K derived: sum of 2 quarters · filed 2024-08-14 | $645.00K 10-Q · filed 2024-11-14 | ||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $645.00K 10-Q · filed 2024-08-14 | |||
| 2023-03-31 | $645.00K 10-Q · filed 2024-05-14 | ||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $4.00K derived: sum of 2 quarters · filed 2023-03-30 | $2.24M 10-K · filed 2023-03-30 | ||
| 2021-09-30 | $4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-12-20 | $2.24M 10-Q · filed 2022-12-20 | |||
| 2021-06-30 | $2.23M 10-Q · filed 2022-12-20 | ||||
| 2021-05-11 | $2.20M 10-Q · filed 2021-08-12 | ||||
| 2020-12-31 | $245.21K 10-K · filed 2021-03-25 | ||||
| 2019-12-31 | $159.89K 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |